Exploratory Analysis of Associations Between Whole Blood Mitochondrial Gene Expression and Cancer-Related Fatigue Among Breast Cancer Survivors
Authors:
- Amber S. KlecknerAKAmber S. Kleckner
- Ian R. KlecknerIKIan R. Kleckner
- Eva CulakovaECEva Culakova
- Andrew P. WojtovichAWAndrew P. Wojtovich
- N. Jennifer KlinedinstNKN. Jennifer Klinedinst
- Sarah L. KernsSKSarah L. Kerns
- Sara J. HardySHSara J. Hardy
- Julia E. InglisJIJulia E. Inglis
- Gilbert D. A. PadulaGPGilbert D. A. Padula
- Karen M. MustianKMKaren M. Mustian
- Michelle C. JanelsinsMJMichelle C. Janelsins
- Susan G. DorseySDSusan G. Dorsey
- 13 April 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Nursing Research
- Vol. 71 (5) , 411-417
Abstract
Background: Cancer-related fatigue is a prevalent, debilitating, and persistent condition. Mitochondrial dysfunction is a putative contributor to cancer-related fatigue, but relationships between mitochondrial function and cancer-related fatigue are not well understood. Objectives: We investigated the relationships between mitochondrial DNA (mtDNA) gene expression and cancer-related fatigue, as well as the effects of fish and soybean oil supplementation on these relationships. Methods: A secondary analysis was performed on data from a randomized controlled trial of breast cancer survivors 4–36 months posttreatment with moderate–severe cancer-related fatigue. Participants were randomized to take 6 g fish oil, 6 g soybean oil, or 3 g each daily for 6 weeks. At pre- and postintervention, participants completed the Functional Assessment of Chronic Illness Therapy–Fatigue questionnaire and provided whole blood for assessment of mtDNA gene expression. The expression of 12 protein-encoding genes was reduced to a single dimension using principal component analysis for use in regression analysis. Relationships between mtDNA expression and cancer-related fatigue were assessed using linear regression. Results: Among 68 participants, cancer-related fatigue improved and expression of all mtDNA genes decreased over 6 weeks with no effect of treatment group on either outcome. Participants with lower baseline mtDNA gene expression had greater improvements in cancer-related fatigue. No significant associations were observed between mtDNA gene expression and cancer-related fatigue at baseline or changes in mtDNA gene expression and changes in cancer-related fatigue. Discussion: Data from this exploratory study add to the growing literature that mitochondrial dysfunction may contribute to the etiology and pathophysiology of cancer-related fatigue.Keywords
This publication has 30 references indexed in Scilit:
- Association of mitochondrial dysfunction and fatigue: A review of the literatureBBA Clinical, 2014
- Mitochondria-Related Gene Expression Changes Are Associated With Fatigue in Patients With Nonmetastatic Prostate Cancer Receiving External Beam Radiation TherapyCancer Nursing, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Cancer‐related fatigueCancer, 2012
- Principal component analysis based methods in bioinformatics studiesBriefings in Bioinformatics, 2011
- Collateral Damage in Cancer Chemotherapy: Oxidative Stress in Nontargeted TissuesMolecular Interventions, 2007
- Dimension Reduction for Classification with Gene Expression Microarray DataStatistical Applications in Genetics and Molecular Biology, 2006
- Tissue‐specific mtDNA lesions and radical‐associated mitochondrial dysfunction in human hearts exposed to doxorubicinThe Journal of Pathology, 2005
- Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement systemJournal of Pain and Symptom Management, 1997
- Sequence and organization of the human mitochondrial genomeNature, 1981